Company Filing History:
Years Active: 2022
Title: Alina Kurolap: Innovator in Therapeutic Antibody Treatments
Introduction: Alina Kurolap is a distinguished inventor based in Haifa, Israel, recognized for her innovative contributions to the field of medicine. With a focus on addressing complex health issues, she has pioneered advancements in the treatment of protein-losing enteropathy.
Latest Patents: Alina holds a patent for the invention titled "Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients." This patent outlines methods for clinically treating conditions such as lymphangiectasia using anti-C5 antibodies or their antigen-binding fragments, aimed particularly at pediatric patients.
Career Highlights: Currently, Alina is employed at Alexion Pharmaceuticals, Inc., where she applies her expertise to advance therapeutic solutions. Her work demonstrates a commitment to enhancing patient care through innovative medical treatments.
Collaborations: Throughout her career, Alina has collaborated with notable coworkers such as Orly Eshach Adiv and Camille Bedrosian. These collaborations highlight her ability to work within a team and contribute to shared goals in the field of medical research.
Conclusion: Alina Kurolap's contributions to the medical field, particularly in the realm of antibody therapies, underscore her role as a leading innovator. With her patent and ongoing work at Alexion Pharmaceuticals, she continues to make significant strides in improving health outcomes for patients battling serious conditions.